Expert and Lay Perceptions of Translation of COVID19 Treatment and Vaccine Development [Funder: MI4]

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    Other Funders (Canada)
  • Principal Investigator

    Kimmelman, Jonathan
  • Research Location

    Canada
  • Lead Research Institution

    McGill University
  • Research Priority Alignment

    N/A
  • Research Category

    Policies for public health, disease control & community resilience

  • Research Subcategory

    Communication

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Worldwide, there are many inaccurate beliefs about medicines and preventative measures that are effective against COVID-19. The result is that some people are self-medicating, hoarding potential treatments, not adhering with self-isolation measures or refusing to participate in critical COVID-19-related studies, all of which can be harmful to themselves and others. Bioethicist Dr. Jonathan Kimmelman and his team are comparing how well researchers' estimates of when COVID-19 treatments will be available align to the perceptions of the Canadian and US populations. The results of this study will help develop more effective communications regarding COVID-19 treatments to the Canadian and US public to ensure they have the best and most accurate information.